You can view the full coverage from day three below
Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
Save the Date for LEAP HR: Life Sciences Europe! 18th-20th February, 2025, London, UK.
